12:00 AM
 | 
Mar 30, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VA111913: Completed Phase I enrollment

Vantia completed enrollment of 99 healthy volunteers in a double-blind, placebo-controlled, single and multiple ascending-dose, U.K. Phase I trial...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >